Daniel Lynch, Director at Blueprint Medicines Corp (BPMC), sold 7,500 shares at $55.06 ($413K) on 2017-07-05, disclosed to the SEC on 2017-07-07.
Open-market sale of $413k BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2025-02-12 | $15.4M | — | Filing → |
| BPMC | SELL | 2018-02-16 | $1.0M | — | Filing → |
| BPMC | SELL | 2018-02-14 | $2.6M | — | Filing → |